| 南京地区22家医院2004～2006年调脂药利用分析 |
| |
| 引用本文： | 邹颖,张吉,冯琳,戴惠珍.南京地区22家医院2004～2006年调脂药利用分析[J].中国药房,2008,19(35):2727-2729. |
| |
| 作者姓名： | 邹颖 张吉 冯琳 戴惠珍 |
| |
| 作者单位： | 南京医科大学第一附属医院药剂科，江苏省医药情报研究所 |
| |
| 摘 要： | 目的:评价南京地区医院调脂药的利用情况及趋势。方法:对南京地区22家医院2004～2006年调脂药的应用品种、销售金额及用药频度等进行统计、分析。结果:3年中南京地区调脂药销售金额逐年增加,主要包括辛伐他汀、血脂康、阿托伐他汀、氟伐他汀、非诺贝特等。结论:他汀类药物占调脂治疗的主导地位,以血脂康为代表的中成药销售前景看好。
|
| 关 键 词： | 调脂药 用药金额 用药频度 |
Analysis on Fat-modulating Drugs Used in 22 Hospitals in Nanjing from 2004 to 2006 |
| |
| ZOU Ying,ZHANG Ji,FENG Lin.Analysis on Fat-modulating Drugs Used in 22 Hospitals in Nanjing from 2004 to 2006[J].China Pharmacy,2008,19(35):2727-2729. |
| |
| Authors: | ZOU Ying ZHANG Ji FENG Lin |
| |
| Institution: | ZOU Ying, ZHANG Ji, FENG Lin,DAI Hui-zhen(1.Dept. of Pharmacy, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China; 2.Research Institute for Medicine Information of Jiangsu Province, Nanjing 210004, China) |
| |
| Abstract: | OBJECTIVE:To evaluate the utilization and tendency of fat-modulating drugs in 22 hospitals in Nanjing. METHODS:The use of fat-modulating drugs in 22 hospitals in Nanjing between 2004 and 2006 were analyzed statistically in terms of drug varieties,consumption sum and DDDs etc. RESULTS:The consumption sum of fat-modulating drugs (predominantly Simvastatin,Xuezhikang,Atorvastatin,Fluvastatin and fenofibrate etc) increased year by year over the three years. CONCLUSION:The statinswas the major choice in treatment for hyperlipoidemia. And the prospect for the consumption of Xuezhikang and other Chinese traditional patent medicines is promising. |
| |
| Keywords: | Fat-modulating drugs Consumption sum DDDs |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
